Skip to main content

Emergent Issues and Future Trends in Familial Adenomatous Polyposis

  • Chapter
Inflammatory Bowel Disease and Familial Adenomatous Polyposis

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bapat BV, Parker JA, Berk T et al (1994) Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines. Dis Colon Rectum 37(2):165–171

    Article  PubMed  CAS  Google Scholar 

  2. Sporn MB (1976) Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 36:2699–2702

    PubMed  CAS  Google Scholar 

  3. Gann PH, Manson JE, Glynn RJ et al (1993) Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85:1220–1224

    Article  PubMed  CAS  Google Scholar 

  4. Baron JA, Cole BF, Sandler RS et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891–899

    Article  PubMed  CAS  Google Scholar 

  5. Sandler RS, Halabi S, Baron JA et al (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348:883–890

    Article  PubMed  CAS  Google Scholar 

  6. Ruschoff J, Wallinger S, Dietmaier W et al (1998) Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci USA 95:11301–11306

    Article  PubMed  CAS  Google Scholar 

  7. Giardiello FM, Hamilton SR, Krush AJ et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313–1316

    Article  PubMed  CAS  Google Scholar 

  8. Steinbach G, Lynch PM, Phillips RKS et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952

    Article  PubMed  CAS  Google Scholar 

  9. Narisawa T, Fukaura Y, Terada K, Sekiguchi H (1998) Prevention of N-methylnitrosourea-induced colon tumorigenesis by ursodeoxycholic acid in F344 rats. Jpn J Cancer Res 89:1009–1013

    PubMed  CAS  Google Scholar 

  10. Rodrigues CM, Kren BT, Steer CJ, Setchell KD (1995) The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation. Gastroenterology 109:1835–1844

    Article  PubMed  CAS  Google Scholar 

  11. Ikegami T, Matsuzaki Y, Shoda J et al (1998) The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A2 expression in colonic tissue. Cancer Lett 134:129–139

    Article  PubMed  CAS  Google Scholar 

  12. Davignon J, Laaksonen R (1999) Low-density lipoprotein-independent effects of statins. Curr Opin Lipidol 10:543–559

    Article  PubMed  CAS  Google Scholar 

  13. Torrance CJ, Jackson PE, Montgomery E et al (2000) Combinatorial chemoprevention of intestinal neoplasia. Nat Med 6:1024–1028

    Article  PubMed  CAS  Google Scholar 

  14. Clapper ML, Chang WC, Meropol NJ (2001) Chemoprevention of colorectal cancer. Curr Opin Oncol 13:307–313

    Article  PubMed  CAS  Google Scholar 

  15. Winde G, Schmid KW, Schlegel W, Fischer R, Osswald H, Bunte H (2005) Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment: advantages of a lowdose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months. Am J Gastroenterol 100(7):1498–1502

    Article  Google Scholar 

  16. de Vos tot Nederveen Cappel WH, Jarvinen HJ, Bjork J et al (2003) Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis. Br J Surg 90(6):705–710

    Article  Google Scholar 

  17. Tulchinsky H, Keidar A, Goldman G et al (2005) Surgical treatment and long-term outcome of patients with familial adenomatous polyposis: 16 years experience at the Tel Aviv Sourasky Medical Center. Isr Med Assoc J 7(2):82–85

    PubMed  Google Scholar 

  18. Lee J, Hargest R, Wasan H, Phillips RKS (2004) Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model. Dis Colon Rectum 47(12):2105–2113

    Article  PubMed  Google Scholar 

  19. Bright-Thomas RM, Agrawal A, Hargest R (2002) Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis. Br J Surg 89(12):1563–1569

    Article  PubMed  CAS  Google Scholar 

  20. Burke CA, Santisi J, Church J, Levinthal G (2005) The utility of capsule endoscopy small bowel surveillance in patients with polyposis. Am J Gastroenterol 100(7):1498–1502

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Delaini, G.G., Scaglia, M., Colucci, G., Öresland, T. (2006). Emergent Issues and Future Trends in Familial Adenomatous Polyposis. In: Delaini, G.G. (eds) Inflammatory Bowel Disease and Familial Adenomatous Polyposis. Springer, Milano. https://doi.org/10.1007/88-470-0434-9_34

Download citation

  • DOI: https://doi.org/10.1007/88-470-0434-9_34

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0433-7

  • Online ISBN: 978-88-470-0434-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics